MDM4 is an oncoprotein that represses the activity of p53, and the authors found that in patients with ovarian cancer the A‐allele MDM4 was associated with better median overall survival versus the miR‐191‐associated C‐allele, especially for women with ER‐negative tumors. This evidence concerns the gene MDM4 and ovarian cancer.